231 related articles for article (PubMed ID: 36834718)
21. Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress.
Hsu NS; Tehei M; Hossain MS; Rosenfeld A; Shiddiky MJA; Sluyter R; Dou SX; Yamauchi Y; Konstantinov K
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2204-2217. PubMed ID: 33399455
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity, cellular uptake and apoptotic responses in human coronary artery endothelial cells exposed to ultrasmall superparamagnetic iron oxide nanoparticles.
Palacios-Hernandez T; Diaz-Diestra DM; Nguyen AK; Skoog SA; Vijaya Chikkaveeraiah B; Tang X; Wu Y; Petrochenko PE; Sussman EM; Goering PL
J Appl Toxicol; 2020 Jul; 40(7):918-930. PubMed ID: 32080871
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.
Ebadi M; Saifullah B; Buskaran K; Hussein MZ; Fakurazi S
Int J Nanomedicine; 2019; 14():6661-6678. PubMed ID: 31695362
[TBL] [Abstract][Full Text] [Related]
25. Sensitization of glioblastoma cancer cells to radiotherapy and magnetic hyperthermia by targeted temozolomide-loaded magnetite tri-block copolymer nanoparticles as a nanotheranostic agent.
Minaei SE; Khoei S; Khoee S; Mahdavi SR
Life Sci; 2022 Oct; 306():120729. PubMed ID: 35753439
[TBL] [Abstract][Full Text] [Related]
26. Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
Yang Y; Guo Q; Peng J; Su J; Lu X; Zhao Y; Qian Z
J Biomed Nanotechnol; 2016 Nov; 12(11):1963-74. PubMed ID: 29363935
[TBL] [Abstract][Full Text] [Related]
27. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity control of silicon nanoparticles by biopolymer coating and ultrasound irradiation for cancer theranostic applications.
Sviridov AP; Osminkina LA; Kharin AY; Gongalsky MB; Kargina JV; Kudryavtsev AA; Bezsudnova YI; Perova TS; Geloen A; Lysenko V; Timoshenko VY
Nanotechnology; 2017 Mar; 28(10):105102. PubMed ID: 28177935
[TBL] [Abstract][Full Text] [Related]
29. Thermo-responsive Fluorescent Nanoparticles for Multimodal Imaging and Treatment of Cancers.
Pandey N; Menon JU; Takahashi M; Hsieh JT; Yang J; Nguyen KT; Wadajkar AS
Nanotheranostics; 2020; 4(1):1-13. PubMed ID: 31911890
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
31. Anti-metastatic breast cancer potential of novel nanocomplexes of diethyldithiocarbamate and green chemically synthesized iron oxide nanoparticles.
Abu-Serie MM; Abdelfattah EZA
Int J Pharm; 2022 Nov; 627():122208. PubMed ID: 36122615
[TBL] [Abstract][Full Text] [Related]
32. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
[TBL] [Abstract][Full Text] [Related]
33. Development of Multifunctional Polydopamine Nanoparticles As a Theranostic Nanoplatform against Cancer Cells.
Wang J; Guo Y; Hu J; Li W; Kang Y; Cao Y; Liu H
Langmuir; 2018 Aug; 34(32):9516-9524. PubMed ID: 30039972
[TBL] [Abstract][Full Text] [Related]
34. Different cell responses induced by exposure to maghemite nanoparticles.
Luengo Y; Nardecchia S; Morales MP; Serrano MC
Nanoscale; 2013 Dec; 5(23):11428-37. PubMed ID: 23963338
[TBL] [Abstract][Full Text] [Related]
35. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
[TBL] [Abstract][Full Text] [Related]
36. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
37. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
38. From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapy.
Li X; Wang X; Zhao C; Shao L; Lu J; Tong Y; Chen L; Cui X; Sun H; Liu J; Li M; Deng X; Wu Y
J Nanobiotechnology; 2019 Feb; 17(1):23. PubMed ID: 30711005
[TBL] [Abstract][Full Text] [Related]
39. Galactomannan armed superparamagnetic iron oxide nanoparticles as a folate receptor targeted multi-functional theranostic agent in the management of cancer.
R S; M Joseph M; Sen A; K RP; Bs U; Tt S
Int J Biol Macromol; 2022 Oct; 219():740-753. PubMed ID: 35907463
[TBL] [Abstract][Full Text] [Related]
40. Enhanced cytotoxic and genotoxic effects of gadolinium-doped ZnO nanoparticles on irradiated lung cancer cells at megavoltage radiation energies.
Zangeneh M; Nedaei HA; Mozdarani H; Mahmoudzadeh A; Salimi M
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109739. PubMed ID: 31349426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
